Fifteen recent publications (2011-2015) :
1. Cambon-Thomsen A, Thorisson Ga, Mabile L on behalf of the BRIF workshop group. The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet, 2011, 43: 503-4
2. Blasimme A, Soulier A Julia S, Leonard S, Cambon-Thomsen A. Disclosing results to genomic research participants: differences that matter. Am J Bioethics, 2012, 12:10, 20-22
3. Kaye J, Meslin E M., Knoppers B M., Juengst E T., Deschênes M, Cambon Thomsen, A, Chalmers D, De Vries J, Edwards K, Hoppe N, Kent A, Adebamowo C, Marshall P, Kato K. ELSI 2.0 for Genomics and Society Science, 2012, 336, 673-674
4. Mahalatchimy A, Rial-Sebbag E, De Grove-Valdeyron N, Tournay V, Cambon-Thomsen A, Duguet Am, Taboulet F. The European Medicines Agency: A Public Health European Agency? Medicine and Law Journal, 2012, Vol. 31, N°1, 25-42
5. Rial-Sebbag E, Cambon-Thomsen A. Emergence of biobanks in the legal landscape: towards a new model of governance. Journal of law and society Vol 39, Number 1, March 2012, 113-30
6. Ruyssen-Witrand A, Constantin A, Cambon-Thomsen A, Thomsen M. New insights into the genetics of immune responses in rheumatoid arthritis. Tissue Antigens, 2012, Aug;80(2):105-18
7. Anastasova V., Blasimme A., Julia S., Cambon-Thomsen A. Genomic incidental findings: reducing the burden to be fair. Am J Bioethics, 2013 Feb;13(2):52-4
8. Anastasova V., Mahalatchimy A., Rial-Sebbag E., Antó Boque J.M., Keil T., Sunyer J., Bousquet J., Cambon-Thomsen A. Communication of results and disclosure of incidental findings in longitudinal paediatric research. Pediatr Allergy Immunol 2013, 24 389-394
9. De Castro, P, Calzolari A,, Napolitani, F, Rossi A M., Mabile, L, Cambon-Thomsen, A, Bravo, E; Open data sharing in the context of bioresources. Acta Inform Med. 2013; 21(4): 291-292
10. Ducournau P., Gourraud Pa., Rial-Sebbag E., Cambon-Thomsen A., Bulle A., Direct-to-consumer health genetic testing services: what commercial strategies for which socio-ethical issues ? Health Sociology Review (2013) 22(1): 75-87
11. Howard H. C., Swinnen E., Douw K., Vondeling H., Jean-Jacques Cassiman J.J., Cambon-Thomsen A., Borry P. on behalf of PHGENII The ethical introduction of genome-based information and technologies into public health. Public health genomics, 2013, 16(3):100-9
12. Mabile L.; Dalgleish R.; Thorisson G. A.; Deschênes M.; Hewitt R; Carpenter J.; Bravo E.; Filocamo M; Gourraud P. A.; Harris J. R.; Hofman P.; Kauffmann F.; Muñoz-Fernàndes M. A.; Pasterk M.; Cambon-Thomsen A.; on behalf of The BRIF working group. Quantifying the use of bioresources for promoting their sharing in scientific research. Giga Science, 2013 May 1;2(1):7
13. Meslin E., Blasimme A., Cambon-Thomsen A. Mapping the Translational Science Policy 'Valley of Death', Clin Transl Med. 2013 Jul 27;2(1):14. [Epub ahead of print]
14. Mahalatchimy A., Rial-Sebbag E., Duguet A.- M., Taboulet F., Cambon-Thomsen A. Impact of European Courts' decisions on embryonic stem cells patents: toward new research strategies. Nat Biotech, 2015, Jan 9, 3: 41-43
15. Bravo E., Calzolari A, De Castro P, Mabile L, Napolitani F, Rossi A M, Cambon-Thomsen A, Developing a guideline for a standardized citation of bioresources in journal articles (CoBRA). BMC Medicine, 2015 http://www.biomedcentral.com/1741-7015/13/33